Keywords: مقاومت غدد درون ریز; Breast cancer; Androgens; Endocrine resistance;
مقالات ISI مقاومت غدد درون ریز (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مقاومت غدد درون ریز; Breast cancer; Estrogen receptor positive; New agents; Endocrine resistance; Biomarkers;
Keywords: مقاومت غدد درون ریز; Breast cancer; Androgen receptor; Anti-androgen therapy; Endocrine resistance;
Keywords: مقاومت غدد درون ریز; Endocrine resistance; Hormone receptor; Estrogen receptor; Breast cancer;
Keywords: مقاومت غدد درون ریز; Endocrine resistance; Breast cancer; Fulvestrant; Palbociclib; Everolimus; Mechanism of resistance;
Keywords: مقاومت غدد درون ریز; Breast cancer; Estrogen receptor; Endocrine resistance; Human epidermal growth factor receptor-2; mTOR; CDK 4/6 inhibitors;
Keywords: مقاومت غدد درون ریز; Advanced breastcancer; Endocrine therapy; Hormone receptor positive; Postmenopausal; Treatment; Maintenance; Endocrine resistance;
Keywords: مقاومت غدد درون ریز; Nuclear receptors; Estrogen; Unfolded protein response; Breast cancer; Endocrine resistance;
Keywords: مقاومت غدد درون ریز; Systems biology; Endocrine resistance; Breast cancer; Computational biology; Unfolded protein response; Tamoxifen; Antiestrogens; Autophagy
Keywords: مقاومت غدد درون ریز; Breast cancer; Tamoxifen; Pluripotency; Endocrine resistance; Transcriptomic analysis; Cell lines; Patient data
Keywords: مقاومت غدد درون ریز; Estrogen signaling; Estrogen receptor; Estradiol; Endocrine resistance; Ovarian cancer;
Keywords: مقاومت غدد درون ریز; AKT; a serine/threonine-specific protein kinase, also known as Protein Kinase B (PKB); CCS; charcoal-stripped fetal-calf serum; CSC; cancer stem cell; E2; 17β-estradiol; E2:ER; E2-bound estrogen receptor; EGFR; epidermal growth factor receptor; ER; estro
ESR1 mutations: Moving towards guiding treatment decision-making in metastatic breast cancer patients
Keywords: مقاومت غدد درون ریز; ESR1 mutations; Metastatic breast cancer; Endocrine resistance; Cell-free DNA;
IL-33 facilitates endocrine resistance of breast cancer by inducing cancer stem cell properties
Keywords: مقاومت غدد درون ریز; Breast cancer; IL-33; Endocrine resistance; Cancer stem cell;
Silencing of MicroRNA-21 confers the sensitivity to tamoxifen and fulvestrant by enhancing autophagic cell death through inhibition of the PI3K-AKT-mTOR pathway in breast cancer cells
Keywords: مقاومت غدد درون ریز; Endocrine resistance; Apoptosis; Autophagy; MiR-21; PI3K-AKT-mTOR
A European Organisation for Research and Treatment of Cancer randomized, double-blind, placebo-controlled, multicentre phase II trial of anastrozole in combination with gefitinib or placebo in hormone receptor-positive advanced breast cancer (NCT00066378)
Keywords: مقاومت غدد درون ریز; Anastrozole; Gefitinib; Metastatic breast cancer; Endocrine resistance;
HOX genes: Major actors in resistance to selective endocrine response modifiers
Keywords: مقاومت غدد درون ریز; HOX gene; Endocrine resistance; Non-coding RNA; Breast cancer;
Unravelling exemestane: From biology to clinical prospects
Keywords: مقاومت غدد درون ریز; AI(s); aromatase inhibitor (s); AKT; protein kinase B; AREG; amphiregulin; BMD; bone mineral density; CYP; cytochrome P450; DHEAS; dehydroepiandrosterone sulfate; EGF; epidermal growth factor; EGFR; epidermal growth factor receptor; EMA; European Medicine
The changing role of ER in endocrine resistance
Keywords: مقاومت غدد درون ریز; Breast cancer; Estrogen receptor; Endocrine resistance; Crosstalk; Co-regulators; ER genomic aberrations;
Recent advances in the treatment of hormone receptor positive HER2 negative metastatic breast cancer
Keywords: مقاومت غدد درون ریز; Targeted agents; Metastatic breast cancer; Endocrine therapy; Endocrine resistance; Next generation sequencing technologies
Cáncer de mama con receptores hormonales positivos: tratamiento adyuvante, primera línea en cáncer metastásico y nuevas estrategias (inhibición de mTOR)
Keywords: مقاومت غدد درون ریز; Cáncer de mama; Resistencia endocrina; Everolimus; Inhibidores de mTOR; TemsirolimusBreast cancer; Endocrine resistance; Everolimus; mTOR inhibitors; Temsirolimus
Targeting the PI3K/AKT/mTOR pathway in estrogen receptor-positive breast cancer
Keywords: مقاومت غدد درون ریز; Luminal type; Breast cancer; Phosphatidylinositol 3-kinase; PI3K; AKT; Mammalian target of rapamycin; mTOR; Estrogen receptor; Endocrine therapy; Endocrine resistance
Steroid receptor coactivator-1: A versatile regulator and promising therapeutic target for breast cancer
Keywords: مقاومت غدد درون ریز; Breast cancer; Coactivator; Steroid receptor coactivator-1; Metastasis; Endocrine resistance;
Original studySafety and Efficacy of Everolimus With Exemestane vs. Exemestane Alone in Elderly Patients With HER2-Negative, Hormone Receptor-Positive Breast Cancer in BOLERO-2
Keywords: مقاومت غدد درون ریز; Advanced breast cancer; Endocrine resistance; Geriatric; Progression-free survival; Safety;
Insulin-like growth factor — Oestradiol crosstalk and mammary gland tumourigenesis
Keywords: مقاومت غدد درون ریز; Insulin-like growth factor; Oestradiol; Breast cancer; Endocrine resistance
mTOR inhibitors in advanced breast cancer: Ready for prime time?
Keywords: مقاومت غدد درون ریز; Advanced breast cancer; Endocrine resistance; Estrogen receptor; Everolimus; Exemestane; Human epidermal growth factor receptor-2; mTOR inhibitor; Progesterone receptor
Endocrine Therapy for Advanced/Metastatic Breast Cancer
Keywords: مقاومت غدد درون ریز; Advanced; Breast cancer; Endocrine resistance; Endocrine therapy; Metastatic;
Activated HER-receptors in predicting outcome of ER-positive breast cancer patients treated with adjuvant endocrine therapy
Keywords: مقاومت غدد درون ریز; Breast cancer; ER-positive; Endocrine resistance; HER-receptors; Phosphorylated HER
Targeted agents to reverse resistance to endocrine therapy in metastatic breast cancer: Where are we now and where are we going?
Keywords: مقاومت غدد درون ریز; Targeted agents; Metastatic breast cancer; Endocrine therapy; Endocrine resistance
The development, application and limitations of breast cancer cell lines to study tamoxifen and aromatase inhibitor resistance
Keywords: مقاومت غدد درون ریز; Models; Endocrine resistance; Tamoxifen; Aromatase inhibitors
An in vitro model showing adaptation to long-term oestrogen deprivation highlights the clinical potential for targeting kinase pathways in combination with aromatase inhibition
Keywords: مقاومت غدد درون ریز; Breast cancer; Oestrogen receptor; Endocrine resistance; Aromatase inhibitor; Kinases;
Prolonged tamoxifen treatment increases relapse-free survival for patients with primary breast cancer expressing high levels of VEGF
Keywords: مقاومت غدد درون ریز; Endocrine resistance; VEGF; Tamoxifen; Endocrine therapy; Growth factor
Molecular mechanisms of endocrine resistance and their implication in the therapy of breast cancer
Keywords: مقاومت غدد درون ریز; Endocrine resistance; Breast cancer; Estrogen receptor; Hormonal therapy
Overexpression of CEACAM6 promotes migration and invasion of oestrogen-deprived breast cancer cells
Keywords: مقاومت غدد درون ریز; Breast cancer; CEACAM6; Invasion and migration; Oestrogen deprivation; Endocrine resistance;
Clinical strategies for rationale combinations of aromatase inhibitors with novel therapies for breast cancer
Keywords: مقاومت غدد درون ریز; Aromatase inhibitors; Endocrine resistance; Fulvestrant; Signal transduction inhibitors; Clinical trials; Endpoints
Summary of aromatase inhibitor trials: The past and future
Keywords: مقاومت غدد درون ریز; Aromatase Inhibitors; Adjuvant Endocrine; Endocrine resistance
c-Myc overexpression and endocrine resistance in breast cancer
Keywords: مقاومت غدد درون ریز; Breast cancer; c-Myc; Endocrine resistance
Aromatase inhibitors: Combinations with fulvestrant or signal transduction inhibitors as a strategy to overcome endocrine resistance
Keywords: مقاومت غدد درون ریز; Aromatase inhibitors; Endocrine resistance; Fulvestrant; Signal transduction inhibitors; Long-term estrogen deprivation;